COMPANY
Mission Bio
Service / Tools company
NIH awards 9
- NIH award 5R44CA247135-02 FY2020: $992,321 awarded for that fiscal year; activity R44 (SBIR); PI RUFF, DAVID W; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. Measureable Residual Disease testing f source ↗
- NIH award 1R44CA247135-01 FY2019: $1,000,002 awarded for that fiscal year; activity R44 (SBIR); PI RUFF, DAVID W; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. Measureable Residual Disease testing source ↗
- NIH award 1R44HG009465-01A1 FY2017: $951,385 awarded for that fiscal year; activity R44 (SBIR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. A robust platform for high-thro source ↗
- NIH award 1R43GM117742-01 FY2016: $199,665 awarded for that fiscal year; activity R43 (SBIR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. Massively parallel quantitative s source ↗
- NIH award 5R44HG007814-03 FY2016: $198,895 awarded for that fiscal year; activity R44 (SBIR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. High-throughput single-cell sorti source ↗
- NIH award 1R43CA199152-01 FY2015: $199,892 awarded for that fiscal year; activity R43 (SBIR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. Molecular characterization of cir source ↗
- NIH award 2R44HG007814-02 FY2015: $904,733 awarded for that fiscal year; activity R44 (SBIR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. High-throughput single-cell sorti source ↗
- NIH award 1R41HG008117-01 FY2014: $215,000 awarded for that fiscal year; activity R41 (STTR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. Amplification-free megabase targe source ↗
- NIH award 1R43HG007814-01 FY2014: $222,889 awarded for that fiscal year; activity R43 (SBIR); PI EASTBURN, DENNIS J; recipient as written: MISSION BIO, INC., SOUTH SAN FRANCISCO, CA. Ultrahigh-throughput single-cell source ↗
Raises and deals from press releases
- Raise Equity financing · amount not disclosed · announced Aug 5, 2025 Company release ↗
Source quote
- Aug 5, 2025 · Company release ↗
“Cato Joining as CCO SOUTH SAN FRANCISCO, Calif., August 5, 2025 – Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group”
- Aug 5, 2025 · Company release ↗